menu search

3 supercharged stocks near 52-week highs that could keep climbing

Reata pharmaceuticals stock is soaring on the back of a recent FDA approval for a new rare disease drug...

March 19, 2023, 6:24 am

Deciphera pharmaceuticals: intrigue phase 3 shows substantial benefit

Deciphera has a strong portfolio of investigational kinase inhibitors, including ripretinib, vimseltinib, and DCC-3116, that have demonstrated encoura...

March 18, 2023, 5:21 am

Relief therapeutics to present pre-clinical evidence for improved amino acid utilization with pku golike at the society for inherited metabolic disorders 44th annual meeting

The results of the preclinical study demonstrate improved muscle anabolism and function with a prolonged-release amino acid supplement using Physiomim...

March 17, 2023, 6:25 pm

Adamis pharmaceuticals corporation (admp) q4 2022 earnings call transcript

Adamis pharmaceuticals Corporation (NASDAQ:ADMP ) Q4 2022 Results Conference Call March 16, 2023 5:00 P...

March 17, 2023, 4:50 pm

Clever leaves reschedules fourth quarter and full year 2022 conference call to thursday, march 30, 2023 at 5:00 p.m. et

TOCANCIPÁ, Colombia, March 17, 2023 (GLOBE NEWSWIRE) -- Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”),...

March 17, 2023, 4:05 pm

Okyo pharma shares soar on news it is gearing up for dry eye disease treatment trial

OKYO Pharma's London-listed shares soared on Friday after the biopharmaceutical company announced it ha...

March 17, 2023, 3:13 pm

Cipher pharmaceuticals inc. (cphrf) q4 2022 earnings call transcript

Cipher pharmaceuticals Inc. (OTCPK:CPHRF) Q4 2022 Earnings Conference Call March 17, 2023 8:30 AM ET Co...

March 17, 2023, 11:48 am

Spectrum pharmaceuticals to report fourth quarter and full year 2022 financial results and provide corporate update

BOSTON--(BUSINESS WIRE)--Spectrum pharmaceuticals, Inc. (NasdaqGS: SPPI), a bio...

March 17, 2023, 7:00 am

Nrx pharmaceuticals to report fourth quarter and full year 2022 financial results on march 30, 2023

RADNOR, Pa. , March 17, 2023 /PRNewswire/ -- NRx pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx ...

March 17, 2023, 6:47 am

Why deciphera pharmaceuticals stock jumped this week

Deciphera focuses on oncology therapies. The company's lead therapy is Qinlock, approved to treat patients with gastrointestinal stromal tumors....

March 16, 2023, 5:25 pm

Acurx pharmaceuticals, inc. (acxp) q4 2022 earnings call transcript

Acurx pharmaceuticals, Inc. (NASDAQ:ACXP ) Q4 2022 Earnings Conference Call March 16, 2023 8:00 AM ET C...

March 16, 2023, 2:20 pm

Catalyst's (cprx) q4 earnings & sales top, boosted by firdapse

Catalyst pharmaceuticals (CPRX) reports better-than-expected financial performance as it beats both ear...

March 16, 2023, 1:46 pm

Biondvax to present at bio-europe spring

JERUSALEM, March 16, 2023 (GLOBE NEWSWIRE) -- via InvestorWire – BiondVax pharmaceuticals Ltd . (Nas...

March 16, 2023, 1:10 pm

Bellicum (blcm) down on ending development of car-t candidates

Following the decision to discontinue the development of pipeline candidates, Bellicum pharmaceuticals ...

March 16, 2023, 1:00 pm

Caterpillar stock appears to be a better pick over this pharmaceuticals giant

We compare their current multiples with the historical ones in the sections below Looking at stock returns, LLY stock has fared better, with a 19% ris...

March 16, 2023, 9:00 am

Valeo pharma reports record 1q revenue and gross profit buoyed by new products and higher market share

Valeo Pharma Inc. (TSX:VPH, OTCQB:VPHIF) said its revenue for the first quarter ended January 31, 2023, rose by 210% to a record $13.2 million, up fro...

March 16, 2023, 7:57 am

Addex announces upcoming conferences it will participate for h1 2023

Geneva, Switzerland, March 16, 202 3  - Addex Therapeutics Ltd (SIX: ADXN, Nasdaq: ADXN), a clinical-stage ph...

March 16, 2023, 2:00 am

Catalyst pharmaceutical (cprx) q4 earnings and revenues surpass estimates

Catalyst (CPRX) delivered earnings and revenue surprises of 4.76% and 0.19%, respectively, for the quarter ended December 2022. Do the numbers hold cl...

March 15, 2023, 7:05 pm

Catalyst pharma the no. 1 biotech, just crushed 2023 guidance estimates

Catalyst pharmaceuticals topped fourth-quarter expectations and delivered strong guidance. In response,...

March 15, 2023, 4:22 pm

Ventyx biosciences to report fourth quarter and full year 2022 financial results on march 23, 2023

ENCINITAS, Calif., March 15, 2023 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX), (“Ventyx”), a clinical-stage bio...

March 15, 2023, 4:05 pm


Search within

Pages Search Results: